Forward Pharma A/S ADR | Income Statement
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cost of Goods Sold (COGS) incl. D&A
4.00
3.00
36.80
108.70
-
4
Gross Income
4.00
3.00
36.80
108.70
-
4
SG&A Expense
9,034.40
17,434.00
49,261.30
55,171.20
36,921.00
12,267.10
EBIT
9,038.40
17,437.00
49,298.10
55,279.90
1,198,020.90
12,271.10
Unusual Expense
6,680.70
6,689.70
-
-
765.30
-
Non Operating Income/Expense
7.00
5,505.60
11,734.10
504.60
3,162.00
3,353.80
Interest Expense
77.10
419.60
-
-
-
-
Pretax Income
15,803.20
18,978.60
37,128.40
54,387.40
1,194,322.40
8,917.40
Income Tax
96.10
246.30
334.10
21,144.00
269,615.10
203.80
Consolidated Net Income
15,707.10
18,732.30
36,794.30
33,243.30
924,707.30
8,713.60
Net Income
15,707.10
18,732.30
36,794.30
33,243.30
924,707.30
8,713.60
Net Income After Extraordinaries
15,707.10
18,732.30
36,794.30
33,243.30
924,707.30
8,713.60
Net Income Available to Common
15,248.80
60,828.90
36,794.30
33,243.30
924,707.30
8,713.60
EPS (Basic)
9.54
1.76
0.79
0.71
4.86
0.18
Basic Shares Outstanding
1,599.00
34,490.00
46,749.00
47,013.00
190,066.50
47,335.50
EPS (Diluted)
9.54
1.76
0.79
0.71
4.64
0.18
Diluted Shares Outstanding
1,599.00
34,490.00
46,749.00
47,013.00
199,471.50
47,335.50
EBITDA
9,034.40
17,434.00
49,261.30
55,171.20
1,198,249.70
12,267.10
Other Operating Expense
-
-
-
-
1,235,170.80
-
Non-Operating Interest Income
-
62.10
435.50
387.90
228.90
-
Preferred Dividends
458.30
42,096.50
-
-
-
-
About Forward Pharma A/S
View Profile
